Royal Bank of Canada
ENZN

Royal Bank of Canada’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Royal Bank of Canada’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-310
Closed – – 6755
2016
Q1 		$0 Buy
310
+300
+3,000% +$146 ﹤0.01% 6966
2015
Q4 		$0 Hold
10
– – ﹤0.01% 7091
2015
Q3 		$0 Hold
10
– – ﹤0.01% 6949
2015
Q2 		$0 Hold
10
– – ﹤0.01% 6865
2015
Q1 		$0 Hold
10
– – ﹤0.01% 6629
2014
Q4 		$0 Hold
10
– – ﹤0.01% 6462
2014
Q3 		$0 Hold
10
– – ﹤0.01% 6289
2014
Q2 		$0 Hold
10
– – ﹤0.01% 6321
2014
Q1 		$0 Hold
10
– – ﹤0.01% 6330
2013
Q4 		$0 Sell
10
-544
-98% -$838 ﹤0.01% 6360
2013
Q3 		$1K Buy
+554
New +$1.02K ﹤0.01% 6021

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $436M AUM 26.61% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Royal Bank of Canada's ENZN Position: Q2 2016 in Review

Royal Bank of Canada sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 310 shares.

Royal Bank of Canada first reported a position in ENZN in Q3 2013 and held it in 11 quarters. The position peaked at $1K in Q3 2013. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Royal Bank of Canada reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Royal Bank of Canada sold 310 ENZON PHARMACEUTICALS INC shares in Q2 2016.
  • Royal Bank of Canada first reported a position in ENZON PHARMACEUTICALS INC in Q3 2013 and held it in 11 quarters.
  • Royal Bank of Canada's ENZON PHARMACEUTICALS INC position peaked at $1K in Q3 2013.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Royal Bank of Canada's 13F filing for Q2 2016, filed 15 Aug 2016.